Superior pathological complete response to neo-adjuvant chemotherapy in breast cancer amongst women with BRCA1/2 mutations.

被引：0
|
作者：
Paluch-Shimon, S. [1 ]
Papa, M. Z. [1 ]
Friedman, E. [1 ]
Shabtai, M. [1 ]
Yosepovich, A. [1 ]
Modiano, T. [1 ]
Goldfarb, A. [1 ]
Catane, R. [1 ]
Kaufman, B. [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：331S / 331S
页数：1
相关论文
共 50 条
  • [1] Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer
    Hubert, Ayala
    Mali, Bela
    Hamburger, Tamar
    Rottenberg, Yakir
    Uziely, Beatrice
    Peretz, Tamar
    Kadouri, Luna
    FAMILIAL CANCER, 2009, 8 (03) : 173 - 177
  • [2] Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer
    Ayala Hubert
    Bela Mali
    Tamar Hamburger
    Yakir Rottenberg
    Beatrice Uziely
    Tamar Peretz
    Luna Kadouri
    Familial Cancer, 2009, 8 : 173 - 177
  • [3] FACTORS ASSOCIATED WITH A COMPLETE PATHOLOGICAL RESPONSE FOLLOWING NEO-ADJUVANT CHEMOTHERAPY FOR BREAST CANCER
    Pryce, Angharad
    Pang, Weehaan
    Francis, Adele
    Rea, Daniel
    EJC SUPPLEMENTS, 2010, 8 (06): : 10 - 11
  • [4] Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers
    T. Byrski
    J. Gronwald
    T. Huzarski
    E. Grzybowska
    M. Budryk
    M. Stawicka
    T. Mierzwa
    M. Szwiec
    R. Wiśniowski
    M. Siolek
    S. A. Narod
    J. Lubinski
    Breast Cancer Research and Treatment, 2008, 108 : 289 - 296
  • [5] Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers
    Byrski, T.
    Gronwald, J.
    Huzarski, T.
    Grzybowska, E.
    Budryk, M.
    Stawicka, M.
    Mierzwa, T.
    Szwiec, M.
    Wisniowski, R.
    Siolek, M.
    Narod, S. A.
    Lubinski, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) : 289 - 296
  • [6] Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriers
    Keet, Annick Wong Wong
    Al-Rafae, Munir
    Chappuis, Pierre O.
    Brunet, Jean-Sebastien
    Ghadirian, Parviz
    Foulkes, William D.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (09) : 2236 - 2238
  • [7] Can MRI be used to determine pathological complete response following neo-adjuvant chemotherapy for breast cancer?
    Sharma, N.
    Dave, R.
    Millican-Slater, R.
    Dodwell, D.
    Horgan, K.
    CANCER RESEARCH, 2016, 76
  • [8] An analysis of response to neo-adjuvant chemotherapy in patients with locally advanced breast cancer with emphasis on pathological complete response
    Narendra, H.
    Thomas, J.
    Ray, S.
    Fernandes, D. J.
    INDIAN JOURNAL OF CANCER, 2014, 51 (04) : 587 - U233
  • [9] Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer
    Van Bockstal, Mieke R.
    Noel, Fanchon
    Guiot, Yves
    Duhoux, Francois P.
    Mazzeo, Filomena
    Van Marcke, Cedric
    Fellah, Latifa
    Ledoux, Benjamin
    Berliere, Martine
    Galant, Christine
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 49
  • [10] ASSOCIATION BETWEEN BRCA1 AND BRCA2 MUTATIONS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN WOMEN WITH BREAST CANCER
    Zhang, Juan
    Yao, Lu
    Liu, Yi Q.
    Yuan, Hua
    Wang, Cheng C.
    Wang, Tong H.
    Sun, Jie
    Ouyang, Tao
    Li, Jin
    Wang, Tian F.
    Fan, Zhao Q.
    Fan, Tie
    Lin, Ben Y.
    Narod, Steven A.
    Xie, Yun T.
    ANTICANCER RESEARCH, 2015, 35 (07) : 4309 - 4310
12345